Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Linical Co Ltd (2183)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
406.0 -9.0    -2.17%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 33,000
  • Bid/Ask: 404.0 / 409.0
  • Day's Range: 405.0 - 419.0
Type:  Equity
Market:  Japan
ISIN:  JP3974530002 
Linical Co Ltd 406.0 -9.0 -2.17%

Linical Co Ltd Company Profile

 
Get an in-depth profile of Linical Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

759

Equity Type

ORD

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Contact Information

Address Shin-Osaka Brick Building 10th Floor
6-1 Miyahara 1-chome Yodogawa-ku Osaka, 532-0003
Japan
Phone 81 6 6150 2478
Fax -

Top Executives

Name Age Since Title
Kazuhiro Hadano 56 - President & Director
Shiori Yamaguchi 47 2007 Chief Compliance Officer, Chief of Audit Office & Executive Director
Jun Kawai 54 2007 Executive VP & Director
Yoshiaki Nakashima - 2020 Independent Outside Director
Yuichi Murakami - 2020 Independent Outside Director
Isao Sakamoto 47 2007 Executive Director
Keigo Tsujimoto 59 2007 Executive VP & Executive Director
Kyoichi Shimomura 79 2020 Independent Outside Director
Satoko Nishimura 56 2023 Independent Outside Director
Yoshimitsu Ando 65 2021 Independent Outside Director
Eri Sugiyama 48 2023 Independent Outside Director
Masaya Miyazaki 52 2006 MD of Head of Asia & Director
Kazuhiro Hatano 58 2005 President, CEO, GM of Corporate and Sales Planning Office & Representative Director
Akihiro Takahashi 56 2007 Senior MD, CFO, GM of Administration Headquarters
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2183 Comments

Write your thoughts about Linical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email